Yesterday, Stellantis made public what its partners in the Symbio hydrogen mobility joint venture have known since May – it is discontinuing its hydrogen fuel cell technology development programme as of 2026. The vehicle maker informed it has “initiated discussions with the shareholders of Symbio to evaluate the current market consequences and to preserve the best interests of Symbio, in line with their respective obligations.” JV partners Michelin and Forvia believe this decision will have “irreversible operational and financial consequences for Symbio” and express concern about the impact upon the firm’s 640 employees.
Membership Required
This is a short extract. Tyrepress and Tyres & Accessories subscribers can log in below to read the full article.
Log in
If you are not yet a Tyrepress or Tyres & Accessories subscriber, you can change that here.
Subscribe now
Becoming a member has benefits such as:
- Read our sector-leading articles in full
- Full analysis of tyre business segments
- Read Tyres & Accessories magazine online/in print
